Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Morenzo Abadi Perkasa Tbk. (ENZO) vs Tempo Scan Pacific Tbk. (TSPC)

Morenzo Abadi Perkasa Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Morenzo Abadi Perkasa Tbk. dan Tempo Scan Pacific Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp75 (kapitalisasi pasar 162,19 M, volume 24 jam 5,64 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 216,9 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 77,6× kapitalisasi pasar Morenzo Abadi Perkasa Tbk., dan Morenzo Abadi Perkasa Tbk. lebih aktif diperdagangkan (5,64 jt vs 216,9 rb). Mana yang lebih baik tergantung tujuan investasimu.

ENZOTSPC
Kapitalisasi Pasar
162,19 M12,58 T
Volume
5,64 jt216,9 rb
Lot
56,36 rb2,17 rb
Perputaran
420,73 jt599 jt
Harga Rata-rata
74,652.761,65
Nilai Transaksi
420,73 jt599 jt
Harga Ekuilibrium Indikatif
752.790
Volume Ekuilibrium Indikatif
16 rb3,9 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ENZO
Lihat detail
TSPC
Lihat detail

Tentang Morenzo Abadi Perkasa Tbk.

PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.

Selengkapnya di halaman ENZO

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC